Stress Management for Cancer Survivors Using a Technologically Adapted Psychosocial Intervention: A Randomized Trial Determining the Effect of Expressive Writing on Psychoneuroimmunology Based Outcomes
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer Survivors
- Sponsor
- Virginia Commonwealth University
- Enrollment
- 40
- Locations
- 1
- Primary Endpoint
- salivary cortisol levels
- Status
- Completed
- Last Updated
- 10 years ago
Overview
Brief Summary
Determine the efficacy of a brief and inexpensive psychosocial intervention, (called expressive writing) in improving health outcomes for cancer survivors.
Detailed Description
This study aims to evaluate a computer-based stress-management therapy called expressive writing. This involves logging in to an online survey and writing in the survey about your thoughts and feelings about your cancer or to type in your everyday experiences. This requires 20-30 minutes of writing a day for 4 consecutive days. You will also provide saliva samples.
Investigators
Eligibility Criteria
Inclusion Criteria
- •have completed their cancer radiation treatment (intent to cure),
- •are cancer free, i.e. do not have currently have a diagnosis of primary/secondary cancer or any recurrence/relapse of cancer,
- •are in the re-entry phase of cancer survivorship, i.e. 2-12 months post-treatment completion,
- •have access to a computer and internet in a private setting, e.g. at home,
- •are fluent in English,
- •are able to provide informed consent.
Exclusion Criteria
- •patients scheduled to undergo any type of cancer treatment (intent to cure/palliative) in the future (e.g. surgery after completing radiation),
- •patients on any kind of corticosteroid medication (e.g. long-term prednisone therapy),
- •patients having any condition that affects function of the adrenal glands (e.g. adrenal hyperplasia),
- •patients with limited ability to produce saliva, e.g. patients that received radiation (or surgery) on the face region or on salivary glands; or patient's suffering from dry mouth (e.g. Sjögren's syndrome),
- •patient's suffering from inflammation of the oral cavity (e.g. gingivitis).
Outcomes
Primary Outcomes
salivary cortisol levels
Time Frame: Up to 6 weeks
Participants will be asked to give their saliva samples through chewable swabs 3 times per day on every day of data collection, i.e. once at baseline, which is 24 hours before the intervention, and twice after the intervention, specifically, 24 hours and 6 weeks post-intervention. Participants will be requested to chew on their swabs and spit into their containers at the following times: 1) immediately after waking up, 2) within 30 min after waking, and 3) immediately before going to sleep.
Secondary Outcomes
- salivary α-amylase and C-Reactive Protein (CRP)(Up to 6 weeks)
- self-reported psychometric measures(Up to 6 weeks)